Evidence-based medicine

Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022

Retrieved on: 
Monday, October 31, 2022
Physician, Patient, Webcast, Company, GLOBE, Evidence-based medicine, Restorative practices, Innovation, Nasdaq, Conference, Hospital

DURHAM, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2022 before the market opens on Tuesday, November 8, 2022.

Key Points: 
  • DURHAM, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2022 before the market opens on Tuesday, November 8, 2022.
  • The Companys management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
  • To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Evidation Launches FluSmart, A Direct-to-Person Digital Flu Monitoring Program, To Better Understand Flu in Everyday Life

Retrieved on: 
Wednesday, October 26, 2022
Other Health, Software, Networks, Professional Services, Pharmaceutical, Data Management, Technology, Infectious Diseases, Data Analytics, Biotechnology, Practice Management, Health, Time, Disease, Life, Machine learning, COVID, Research, Twitter, Program, Multimedia, Health, Risk, Algorithm, Influenza-like illness, Dietary supplement, Medical device, Evidence-based medicine, Other Health, Software, Networks, Professional Services, Pharmaceutical, Data Management, Technology, Infectious Diseases, Data Analytics, Biotechnology, Practice Management, Health

Evidation, the company that connects directly with individuals to measure health in everyday life, has launched FluSmart, a digital flu monitoring program that brings together individuals, researchers, and public and private organizations to understand flu at its earliest stages.

Key Points: 
  • Evidation, the company that connects directly with individuals to measure health in everyday life, has launched FluSmart, a digital flu monitoring program that brings together individuals, researchers, and public and private organizations to understand flu at its earliest stages.
  • View the full release here: https://www.businesswire.com/news/home/20221026005641/en/
    Evidations FluSmart is a nationwide program that helps people proactively understand risk factors for flu and provides personalized insights related to flu and influenza-like illness.
  • Individuals can report flu symptoms at any time and do not need a wearable to participate in the program.
  • Evidation has developed machine learning detection models to compare flu and COVID and validated and extended this work with collaborators .

Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022

Retrieved on: 
Thursday, October 20, 2022
Nova Scotia Health Authority, PALO, Thought, Machine learning, Annual, Radiographer, Treatment, Feasibility study, Strathcona County, Central Time, IMV, Society, Evidence-based medicine, Patient, Twitter, Program, AOS, Science, MRI, Partnership, Artificial intelligence, Cancer, Technology, CT, NUALS Arts and Literary Annual Meet, American Society of Radiologic Technologists, Goal, Solution, Google Images, American Society for Radiation Oncology, Doctor of Philosophy, Radiation therapy, ASTRO, CEO, Siemens Healthineers, ASRT, Clinical trial, Physics, Clinical research, Radiation, Ayala Corporation, Medical imaging, Pharmaceutical industry, Ethos, PET/CT, Varian

The combined company addresses the full cancer care continuum, and is working to create an oncology ecosystem to support care providers along the entire cancer care journey from screening to survivorship.

Key Points: 
  • The combined company addresses the full cancer care continuum, and is working to create an oncology ecosystem to support care providers along the entire cancer care journey from screening to survivorship.
  • The innovative products, technologies, and clinical research Varian will feature during this year's show reflect the company's evolution into a comprehensive cancer care company and commitment to helping care providers make more informed decisions at every point of the cancer care journey.
  • Connected Imaging: As a Siemens Healthineers company, Varian is enabling greater personalization of cancer care through multimodality imaging and connecting oncology teams with advanced imaging capabilities inside and outside the treatment vault.
  • With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care.

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago   

Retrieved on: 
Wednesday, October 12, 2022
Vestibular adenitis, LinkedIn, Innovation, Lipoma, Decompression, Ultrasound, Injury, Pelvis, Securities Act of 1933, Spine, Leiomyoma, NEXUS, Ovary, Inclusion, Failure, Surgeon, Cardiothoracic surgery, Evidence-based medicine, Twitter, Access, North American Spine Society, Company, Gastrointestinal tract, Orthopedic surgery, GLOBE, Uterine fibroid, Projection, Government, Growth, Review, Uterus, Research, Security (finance), NASS, Neurosurgery, Plastic and Reconstructive Surgery, Securities Exchange Act of 1934, MIS, U.S. Securities and Exchange Commission, General surgery, Sebaceous cyst, Terminology, Risk, Physician, Cedars-Sinai Medical Center, SEC, Patient, Nasdaq, Malignancy, Sex, Acquisition, Extremities, Forward-looking statement, COVID-19, Cardiac fibroma, Sebaceous gland, Bookbinding, Medical imaging, Gynaecology, MD

The BoneScalpel Access handpiece 20 mm blade and Micro Hook Shaver will be available throughout the U.S. on October 17.

Key Points: 
  • The BoneScalpel Access handpiece 20 mm blade and Micro Hook Shaver will be available throughout the U.S. on October 17.
  • The BoneScalpel Access handpiece allows surgeons to leverage the many advantages of ultrasonic bone cutting in minimally invasive spinal procedures.
  • Combined with OSTEOAMP Flowable, Bioventus now has a full portfolio for MIS spine procedures, the fastest growing segment of spine surgery.
  • The Bioventus surgical solutions portfolio brings together innovative products that add value for surgical applications in decompression and fusion.

Breaking Data on the Efficacy and Cost-Effectiveness of an Exclusive Human Milk Diet for Premature Infants To Be Presented at the American Academy of Pediatrics 2022 National Conference

Retrieved on: 
Friday, October 7, 2022
AAP, Method, LinkedIn, Late preterm infant, Jean-Louis Vincent, Lactoferrin, Growth, Hospital, Conference, Infant, Premature, Immunity, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Evidence-based medicine, Patient, Research, Twitter, Pacific Time Zone, Instagram, Virginia Commonwealth University, MPH, Science, Milk, Food, Health maintenance organization, FDA Adverse Event Reporting System, American Academy of Pediatrics, Mortality, Doctor of Philosophy, Antibody, Health, Pasteurization, ELBW, Disease, National Conference, Nutritional science, Children's Hospital, Safety, NICU, American Academy, Anaheim Convention Center, UHT, Meta-analysis, VLBW, FDA, Pharmaceutical industry, Facebook, MD

One study based on real-world data from seven U.S. hospitalsdemonstrates the efficacy and cost-effectiveness of an EHMD for premature infants.

Key Points: 
  • One study based on real-world data from seven U.S. hospitalsdemonstrates the efficacy and cost-effectiveness of an EHMD for premature infants.
  • "These collaborative data fill gaps in evidence-based medicine for NICU leaders and provide support for implementing an EHMD for very preterm infants," Dr. Fox said.
  • The major difference between cow milk-based and human milk-based products is the composition notably, the bioactive components that are unique to human milk.
  • Prolacta maintains the industry's strictest quality and safety standards for screening, testing, and processing donor human milk.

WETHRIVV® LLC Expands Maskād® Products to Include Direct-to-Consumer

Retrieved on: 
Monday, October 3, 2022
Barber Pro Series, Consumer, Peptide, Human, Serum, Fetus, Technology, Research, Evidence-based medicine, Delivery, Ageing, Diffusion, Science, Mask, Plant, Cosmetics, Fine chemical

DOYLESTOWN, Pa., Oct. 3, 2022 /PRNewswire/ -- Amy and Sanjay Batra are excited to launch their Maskād® consumer line. Using the same science-based and clean-ingredient approach as Maskād Pro Series, they created a system that includes a derma roller, growth factor and peptide serum, hyaluronic acid serum and face mask.

Key Points: 
  • DOYLESTOWN, Pa., Oct. 3, 2022 /PRNewswire/ --Amy and Sanjay Batra are excited to launch their Maskd consumer line.
  • It is a pleasure to collaborate with them and support the science and research of the Maskd product portfolio".
  • Controlled clinical studies have shown that products containing growth factors:
    The Maskd Hydrating Serum is clean and simple - comprised of only 3 ingredients and available in 2 sizes.
  • WETHRIVV LLC is methodically creating a portfolio of professional and consumer products poised to elevate customer experience and satisfaction in facial aesthetics and hair growth markets.

Forsyth Orthodontic Symposium Introduces New Organization to the World - Exciting New Education Programs & Research Grants with Mission for the Next Medical Breakthrough

Retrieved on: 
Tuesday, September 27, 2022
Dai, Adult, Definitive, Malocclusion, Symposium, Showcase, Research, West Virginia University, Dream, Face, Partnership, American Association, Continuing education, Industry, The Forsyth Institute, Evidence-based medicine, Program, Virginia University, IOF, CE, Align Technology, Patient, OSA, Harvard Medical School, Association, Education, Communication, Dentistry, Medical device, Pharmaceutical industry, Orthodontics

This event is initiated by the leading stomatological institutions, bringing together leaders of Orthodontic Programs across the United States.

Key Points: 
  • This event is initiated by the leading stomatological institutions, bringing together leaders of Orthodontic Programs across the United States.
  • In partnership with the Forsyth Institute, IOF is a proud sponsor of this event and an active participant.
  • The objective of the Symposium is to encourage exchanges, education, and training on subjects covering both academic and clinical applications.
  • Research - Support orthodontic clinicians and researchers to realize their dreams through research grants.

Medical Education Market to Expand at ~5% CAGR during Forecast Period: TMR Study

Retrieved on: 
Monday, September 26, 2022
Online, Income, TMR, Education, Efficiency, American Medical Association, Investor, Evidence-based medicine, Patient, Curriculum, Physician, Prognosis, Diagnosis, US, Research, AI, Informatics, CAGR, Medicine

By 2030, the medical education market is estimated to touch value of 56.9 Bn.The American Medical Association is becoming more well-known for driving progress in the field of medical education.

Key Points: 
  • By 2030, the medical education market is estimated to touch value of 56.9 Bn.The American Medical Association is becoming more well-known for driving progress in the field of medical education.
  • Both graduate and undergraduate medical education faculties are being rewarded with innovation grant schemesto improve the medical education sector.
  • North America is expected to be the fastest growing market for medical education during the forecast period.
  • Leading players in the medical education market are able to diversify their sources of income owing to increasing adoptionof cutting-edge technologiesand AI, which are expected to be recent developments in medical education market.

Medical Education Market to Expand at ~5% CAGR during Forecast Period: TMR Study

Retrieved on: 
Monday, September 26, 2022
Online, Income, TMR, Education, Efficiency, American Medical Association, Investor, Evidence-based medicine, Patient, Curriculum, Physician, Prognosis, Diagnosis, US, Research, AI, Informatics, CAGR, Medicine

By 2030, the medical education market is estimated to touch value of 56.9 Bn.The American Medical Association is becoming more well-known for driving progress in the field of medical education.

Key Points: 
  • By 2030, the medical education market is estimated to touch value of 56.9 Bn.The American Medical Association is becoming more well-known for driving progress in the field of medical education.
  • Both graduate and undergraduate medical education faculties are being rewarded with innovation grant schemesto improve the medical education sector.
  • North America is expected to be the fastest growing market for medical education during the forecast period.
  • Leading players in the medical education market are able to diversify their sources of income owing to increasing adoptionof cutting-edge technologiesand AI, which are expected to be recent developments in medical education market.

AvoMD Now Available on Epic's App Orchard, for Free

Retrieved on: 
Wednesday, September 7, 2022
Epic Systems, Evidence-based medicine, American Academy, Documentation, Society of Cardiovascular Computed Tomography, Time, News, EHR, Hospital, Multimedia, API, Laika (EHR testing framework), American Academy of Family Physicians, Web browser, U.S. News & World Report, Kidney disease, Algorithm, Automation, Society, Orchard, Medical device, Pharmaceutical industry, Online shopping

AvoMD joins only a handful of applications available as publicly listed clinical decision support tools on the Epic App Orchard.

Key Points: 
  • AvoMD joins only a handful of applications available as publicly listed clinical decision support tools on the Epic App Orchard.
  • AvoMD provides clinicians with instant, interactive access to evidence-based clinical guidelines and clinical pathways at the point-of-care.
  • The majority of these modules are available for free, underscoring AvoMD's mission to bridge the divide between evidence and practice.
  • In addition to using AvoMD natively through Epic's App Orchard, clinicians can use AvoMD on their web browser , on a mobile app , or on other EHR systems .